Skip to main content
Find a Lawyer

all - Opinion Summaries

FILL IN AT LEAST ONE FIELD

Format is YYYYMMDD

Page 9 of 88 Showing Result 81 - 90 of 874
Description Date Docket #

Bristol-Myers Squibb Co. v. Superior Court

Supreme Court of California
Civil Procedure, Class Actions, Drugs & Biotech
In a civil procedure action, arising over patient injuries from taking Plavix, the Court of Appeal's judgment is affirmed where defendant's business...
08/29/2016 S221038

The Medicines Co. v. Hospira, Inc.

United States Federal Circuit
Intellectual Property, Commercial Law, Patent, Drugs & Biotech
In a case arising from the submission of two Abbreviated New Drug Applications (ANDAs) for generic bivalirudin drug products before the expiration of...
07/11/2016 14-1469

Amgen Inc. v. Apotex Inc.

United States Federal Circuit
Intellectual Property, Patent, Drugs & Biotech
In an infringement suit brought under the Biologics Price Competition and Innovation Act of 2009 (BPCIA), involving a proposed biosimilar product to...
07/05/2016 2016-1308

Rapid Litigation Management, Ltd. v. CellzDirect, Inc.

United States Federal Circuit
Intellectual Property, Patent, Drugs & Biotech
In an infringement action involving a patent for an improved process of preserving hepatocytes, the District Court's summary judgment of invalidity...
07/05/2016 2015-1570

Garcia v. Novartis Pharmaceuticals

United States First Circuit
Injury & Tort Law, Drugs & Biotech
In qui tam actions under the False Claims Act (FCA), 31 U.S.C. section 3729 et seq., and related state statutes, alleging defendants caused physicians...
06/17/2016 15-1470

Genzyme Therapeutic Prods. Ltd. P'ship v. Biomarin Pharm. Inc.

United States Federal Circuit
Intellectual Property, Patent, Drugs & Biotech
In an appeal from decisions of the Patent Trial and Appeal Board in two inter partes review proceedings involving patents directed to treating Pompe's...
06/14/2016 2015-1720, 2015-1721

Hochendoner v. Genzyme Corp.

United States First Circuit
Civil Procedure, Drugs & Biotech
In consolidated actions arising out of the shortage of a medication that treats Fabry Disease, a rare genetic disorder that leaves afflicted persons...
05/23/2016 15-1446, 15-1447

US ex rel. Polansky v. Pfizer

United States Second Circuit
Consumer Protection Law, False Advertising, Drugs & Biotech
In an action brought under the False Claims Act (FCA) and state analog causes of action against plaintiff's former employer, alleging it improperly...
05/17/2016 14-4774

Intendis, GmbH v. Glenmark Pharms. Inc.

United States Federal Circuit
Intellectual Property, Patent, Drugs & Biotech
In a case arising under the Hatch-Waxman Act involving a proposed generic version of Finacea Gel, a topical medication for various skin disorders, the...
05/16/2016 2015-1902

Apotex Inc., et al., v. Acorda Therapeutics, Inc.

United States Second Circuit
False Advertising, Drugs & Biotech, Antitrust & Trade Regulation
In a suit between rival manufacturers of tizanidine, a drug for treating spasticity, dealing with the circumstances under which the filing of a...
05/16/2016 14-4353-cv

Results 81 to 90 of 874

Copied to clipboard